Cargando…
SOX5 predicts poor prognosis in lung adenocarcinoma and promotes tumor metastasis through epithelial-mesenchymal transition
Lung cancer is the leading cause of cancer-related death worldwide. Epithelial-mesenchymal transition (EMT) promotes lung cancer progression and metastasis, especially in lung adenocarcinoma. Sex determining region Y-box protein 5 (SOX5) is known to stimulate the progression of various cancers. Here...
Autores principales: | Chen, Xin, Fu, Yufei, Xu, Hongfei, Teng, Peng, Xie, Qiong, Zhang, Yiran, Yan, Caochong, Xu, Yiqiao, Li, Chunqi, Zhou, Jianying, Ni, Yiming, Li, Weidong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5834284/ https://www.ncbi.nlm.nih.gov/pubmed/29541384 http://dx.doi.org/10.18632/oncotarget.22443 |
Ejemplares similares
-
SOX5 induces lung adenocarcinoma angiogenesis by inducing the expression of VEGF through STAT3 signaling
por: Chen, Xin, et al.
Publicado: (2018) -
RUFY3 Predicts Poor Prognosis and Promotes Metastasis through Epithelial-mesenchymal Transition in Lung Adenocarcinoma
por: Men, Wanfu, et al.
Publicado: (2019) -
Integrative analysis reveals a clinicogenomic landscape associated with liver metastasis and poor prognosis in hepatoid adenocarcinoma of the stomach
por: Jiang, Junjie, et al.
Publicado: (2022) -
Sema3C promotes hepatic metastasis and predicts poor prognosis in gastric adenocarcinoma
por: Li, Maoran, et al.
Publicado: (2021) -
Expression of OPN3 in lung adenocarcinoma promotes epithelial‐mesenchymal transition and tumor metastasis
por: Xu, Chao, et al.
Publicado: (2019)